Design and development of 6-hydrazinonicotinyl-fatty acid-mimetic 99mTc-complex as a potential myocardial imaging agent
DOI:
https://doi.org/10.1590/Keywords:
Technetium, Radiopharmaceutical, Myocardial metabolism, Long chain amideAbstract
The goal of this work is to identify new fatty acid-mimetic 99mTc-complexes to be used as myocardial imaging agents that allow studying heart abnormalities in high-risk patients. In this sense, we designed a fatty acid-mimetic substructure including an amide moiety that, among other properties, could improve myocardial residence time. A diamide with a chain length of 15 atoms and porting a 6-hydrazinonicotinyl (HYNIC) chelator, and an analog with a short carbon-chain, were prepared with convergent organic synthetic procedures and radiolabeled with 99mTc using tricine as the sole coligand. The in vivo proofs of concept were performed using healthy mice. The new 99mTc-complexes were obtained with adequate radiochemical purity. The lipophilicities were in agreement with the length of the chains. While both 99mTc-complexes showed uptake in the myocardial muscle, the designed radiopharmaceutical with the longest chain length had preferential target-uptake and target-retention compared to other complexes described in the bibliography. Further studies, involving imaging assays, synthetic modifications, and assay of new coligands for 99mTc-HYNIC complexes, are currently ongoing.
Downloads
References
Calzada V, Moreno M, Newton J, González J, Fernández M, Gambini JP, et al. Development of new PTK7-targeting aptamer-fluorescent and -radiolabelled probes for evaluation as molecular imaging agents: Lymphoma and melanoma in vivo proof of concept. Bioorg Med Chem. 2017;25(3):1163-71.
Corbett JR. Fatty acids for myocardial imaging. Semin Nucl Med. 1999;29(3):237-58.
García MF, Calzada V, Camacho X, Goicochea E, Gambini JP, Quinn TP, et al. Microwave-assisted synthesis of HYNIC protected analogue for 99mTc labeled antibody. Curr Radiopharm. 2014;7(2):84-90.
Gavande N, Kim HL, Doddareddy MR, Johnston GAR, Chebib M, Hanrahan JR. Design, synthesis, and pharmacological evaluation of fluorescent and biotinylated antagonists of ρ1 GABAC receptors. ACS Med Chem Lett. 2013;4(4):402-7.
Kaiser KP, Geuting B, Grossmann K, Vester E, Losse B, Antar MA, et al. Tracer kinetics of 15-(ortho-123/131I-phenyl)-pentadecanoic acid (oPPA) and 15-(para-123/131I-phenyl)-pentadecanoic acid (pPPA) in animals and man. J Nucl Med. 1990;31(10):1608-16.
Knapp FF, Ambrose KR, Goodman MM. New radioiodinated methyl-branched fatty acids for cardiac studies. Eur J Nucl Med . 1986;12(Suppl):S39-S44.
Lee BC, Kim DH, Lee JH, Sung HJ, Choe YS, Chi DY, et al. 99mTc(CO) -15-[N-(acetyloxy)-2-picolylamino]pentadecanoic acid: A potential radiotracer for evaluation of fatty acid metabolism. Bioconj Chem. 2007;18(4):1332-7.
Machulla HJ, Stocklin G, Kupfernagel C, Freundlieb C, Hock A, Vyska K, et al. Comparative evaluation of fatty acids labeled with C-11, Cl-34 m, Br-77, and I-123 for metabolic studies of the myocardium: Concise communication. J Nucl Med . 1978;19(3):298-302.
Mathur A, Subramanian S, Mallia MB, Banerjee S, Samuel G, Sarma HD, et al. Synthesis and bio-evaluation of a new fatty acid derivative for myocardial imaging. Bioorg Med Chem . 2008;16(17):7927-31.
Mathur A, Sharma AK, Murhekar VV, Madhava B. Mallia MB, Pawade S, et al. Syntheses and biological evaluation of 99mTc-HYNIC-fatty acid complexes for myocardial imaging. RSC Adv. 2015;5(113):93374-85.
Messina SA, Aras O, Dilsizian V. Delayed recovery of fatty acid metabolism after transient myocardial ischemia: A potential imaging target for “Ischemic Memory”. Curr Cardiol Rep. 2007;9(2):159-65.
Meszaros LK, Dose A, Biagini SCG, Blower PJ. Hydrazinonicotinic acid (HYNIC) - Coordination chemistry and applications in radiopharmaceutical chemistry. Inorg Chim Acta. 2010;363(6):1059-69.
Mirtschink P, Stehr SN, Walther M, Pietzsch J, Bergmann R, Pietzsch H-J, et al. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging. Part 1: Myocardial extraction and biodistribution. Nucl Med Biol. 2009a;36(7):833-43.
Mirtschink P, Stehr SN, Walther M, Pietzsch J, Bergmann R, Pietzsch H-J, et al. Validation of 99mTc-labeled “4+1” fatty acids for myocardial metabolism and flow imaging. Part 2: Subcellular distribution. Nucl Med Biol . 2009b;36(7):845-52.
Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949-3003.
Morton DB, Griffiths PHM. Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessment. Vet Record. 1985;116(16):431-6.
Otto CA, Brown LE, Wieland DM, Beierwaltes WH. Radioiodinated fatty acids for myocardial imagine: Effects of chain length. J Nucl Med . 1981;22(7):613-8.
Schwenk RW, Luiken JJ, Bonen A, Glatz JF. Regulation of sarcolemmal glucose and fatty acid transporters in cardiac disease. Cardiovasc Res. 2008;79(2):249-58.
Tamaki N, Morita K, Kuge Y, Tsukamoto E. The role of fatty acids in cardiac imaging. J Nuc Med. 2000;41(9):1525-34.
Zeng H, Zhang H. Synthesis and biological evaluation of fatty acids conjugates bearing cyclopentadienyl-donors incorporated [99mTc/Re(CO) ]+ for myocardical imaging. Eur J Med Chem. 2014;72:10-7.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Brazilian Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
All content of the journal, except where identified, is licensed under a Creative Commons attribution-type BY.
The on-line journal has open and free access.
